| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |